Earnings Call Insights: Precigen, Inc. (PGEN) Q4 2025 Management View Helen Sabzevari, President and CEO, highlighted the company's transformation to a "product revenue-generating commercial biotech company" following the full FDA approval and commercial launch of PAPZIMEOS, the first therapeutic for adult recurrent respiratory papillomatosis (RRP). She reported, "net product revenue for Q4 2025 w...
Earnings Call Insights: Precigen, Inc. (PGEN) Q4 2025 Management View Helen Sabzevari, President and CEO, highlighted the company's transformation to a "product revenue-generating commercial biotech company" following the full FDA approval and commercial launch of PAPZIMEOS, the first therapeutic for adult recurrent respiratory papillomatosis (RRP). She reported, "net product revenue for Q4 2025 was $3.4 million, with shipments commencing in November" and stated, "we expect revenues in Q1 to exceed $18 million." Sabzevari emphasized PAPZIMEOS' "broad label for adult RRP with no restriction based on the number of prior surgeries" and underscored its "unmatched efficacy" and "durable ongoing responses," citing more than three years of follow-up in clinical studies. She noted a consensus paper published by 16 leading U.S. physicians recommending PAPZIMEOS as the "preferred first-line treatment for adults with recurrent respiratory papillomatosis." Phil Tennant, Chief Commercial Officer, described the rapid expansion of payer coverage, stating, "In early January, we had approximately 170 million lives covered, which has now increased to approximately 215 million, including nearly all major payers across commercial, Medicare and Medicaid." Tennant reported over 300 patients in the Precigen patient support hub and observed, "Brand utilization is accelerating across the country in both the large institutions and academic centers as well as in the community setting." Harry Thomasian, Chief Financial Officer, stated, "Revenue for the year totaled $9.7 million versus $3.9 million in 2024, resulting in an increase of $5.8 million or 149%." He added, "We expect revenue for Q1 of 2026 will exceed $18 million." Thomasian also noted, "Our net loss attributable to common shareholders was $429.6 million, or $1.37 per share for the year ended December 31, 2025," with two large noncash items totaling $318.5 million or $1.02 per share, which "will not recur in the future." Sabzevari an...
Lima The Environmental Protection Agency issued a temporary waiver Wednesday to allow the nationwide sale of E15 ethanol gasoline, as part of an effort to maintain domestic supplies and ease prices at the gasoline pump that have surged because of war in the Middle East. The waiver, which takes effect for 20 days starting May 1 and can be extended if needed, will allow retailers to sell less expen...
Lima The Environmental Protection Agency issued a temporary waiver Wednesday to allow the nationwide sale of E15 ethanol gasoline, as part of an effort to maintain domestic supplies and ease prices at the gasoline pump that have surged because of war in the Middle East. The waiver, which takes effect for 20 days starting May 1 and can be extended if needed, will allow retailers to sell less expensive formulations of gasoline, including mixtures that include 15% ethanol, that are typically not permitted during warmer months. The EPA's action also will remove all federal impediments to selling E10—gasoline blended with 10% ethanol—across the country, including in a group of seven Midwestern states that would have otherwise required that blend to be mixed with less volatile but costlier blendstocks . Analysts said the moves could trim several cents per gallon off retail prices; the U.S. average price for regular gasoline is running just over $3.98/gal, up more than a dollar from a month ago, according to AAA. "We foresee potential for a disruption to the American fuel supply," EPA Administrator Zeldin said at a press conference at the CERAWeek energy conference in Houston, where the waiver was announced. Potential relevant stocks include Valero Energy ( VLO ), Marathon Petroleum ( MPC ), Phillips 66 ( PSX ), HF Sinclair ( DINO ), PBF Energy ( PBF ), Delek US ( DK ), Archer Daniels Midland ( ADM ), Bunge ( BG ), Green Plains ( GPRE ), Gevo ( GEVO ), Clean Energy Fuels ( CLNE ), REX American Resources ( REX ), Darling Ingredients ( DAR ), FutureFuel ( FF ). ETF: ( CRAK ) More on Valero Energy and Archer Daniels Midland Valero Is Much More Than Fossil Based Crack Spreads Valero Energy: Still Pumping Cash, But The Valuation Looks Bloated Archer Daniels Midland: Policy Wins Don't Fix This Dividend King's Valuation
imaginima/iStock via Getty Images I previously covered American Tower Corporation ( AMT ) in December 2025, discussing why I had reiterated my Buy rating then, thanks to the excellent margin of safety arising from the steep correction/discounted valuations, the reasonable technical indicators, and the robust dual pronged return prospects across capital appreciation/dividend incomes. In this articl...
imaginima/iStock via Getty Images I previously covered American Tower Corporation ( AMT ) in December 2025, discussing why I had reiterated my Buy rating then, thanks to the excellent margin of safety arising from the steep correction/discounted valuations, the reasonable technical indicators, and the robust dual pronged return prospects across capital appreciation/dividend incomes. In this article, I shall discuss why I am reiterating my Buy rating for the AMT stock here, thanks to the mixed optics from the tenant default/underwhelming FY2026 guidance already triggering the stock price selloff and the consequently cheap valuations/richer dividend yields. My optimism is further aided by the REIT's diversified growth/monetization tailwinds across the legacy telecom and data center opportunities, during the multi-year 5G/6G/AI-related boom. AMT's Tenant Headwinds Discussed AMT 1Y Stock Price (Trading View) Since my last Buy rating, AMT has missed the great market rotation in December 2025, with the telecom/data center REIT seemingly left in the dust, similar to another pure-play telecom REIT, Crown Castle Inc. ( CCI ). Part of AMT's headwinds may be attributed to the prior default of DISH Wireless , a tenant that comprises 2% of the REIT's consolidated property revenue and 4% of the UCAN property revenues in FY2025, with it directly contributing to the REIT's impacted FY2026 guidance as the management "continue to pursue legal action to recover the value of its remaining lease obligations." For reference, AMT has offered an underwhelming FY2026 guidance at: the consolidated organic tenant billings growth at approximately +2% YoY, the adj EBITDA growth at approximately -0.1% YoY, the AFFO per share growth at approximately +1% YoY, against the FY2025 outperformance at +5.1% YoY, +4.7% YoY, and +8% YoY, respectively. When compared to AMT's historical top/bottom-line (AFFO per share) growth profile at a 5Y CAGR of +5.8%/+5.9% and 10Y CAGR of +8.4%/+7.8%, respectively, I c...
Hot Pot, Hot Mess: Service Robot Goes Berserk In San Jose Dining Room, Must Be Tackled By Staff On Tuesday, diners at a Haidilao hot-pot restaurant in San Jose saw an unexpected disruption when a service robot, apparently part of an in-house performance, malfunctioned and began moving erratically. Instead of entertaining guests, it knocked dishes to the floor and sent chopsticks flying as employee...
Hot Pot, Hot Mess: Service Robot Goes Berserk In San Jose Dining Room, Must Be Tackled By Staff On Tuesday, diners at a Haidilao hot-pot restaurant in San Jose saw an unexpected disruption when a service robot, apparently part of an in-house performance, malfunctioned and began moving erratically. Instead of entertaining guests, it knocked dishes to the floor and sent chopsticks flying as employees rushed to contain it. Video from the scene shows staff dodging the machine before eventually tackling it; no injuries are apparent, Hoodline wrote . A malfunctioning service robot dances uncontrollably at a Haidilao hotpot restaurant in San Jose, California, knocking over tableware as staff members attempt to restrain it, March 2026. pic.twitter.com/6DFCojpeTS — Future Adam Curtis B-Roll (@adamcurtisbroll) March 17, 2026 A short clip shared online captures the robot, dressed in an orange apron, flailing through the dining area and upsetting tableware. At one point, a worker appears to grab it near the neck while looking at a phone, seemingly trying to access controls as the situation unfolds. The episode comes amid Haidilao’s broader push into automation. The company has spent years integrating technology into its restaurants, including delivery robots and highly automated kitchens. It also introduced a pilot “smart” restaurant in Beijing in 2018 that relied on robotic arms and guided vehicles. After the footage spread, many online commenters focused on how the robot was shut down. Some pointed out that no obvious emergency stop button was visible and questioned whether clearer manual override systems should be required in restaurants using such machines. Reports indicate the robot appeared as part of a promotional tie-in for Disney’s “Zootopia 2.” The incident has renewed concerns about how quickly staff can intervene and safely regain control when robotic systems malfunction in crowded public spaces. Tyler Durden Wed, 03/25/2026 - 18:50
Rolf Stangl, a director at Reynolds Consumer Products (NASDAQ:REYN) , reported the purchase of 4,705 common shares in open-market transactions on March 18, 2026, valued at approximately $99,000, according to an SEC Form 4 filing . Transaction value based on SEC Form 4 weighted average purchase price ($21.06). Reynolds Consumer Products Inc. is a leading producer of consumer packaging and disposabl...
Rolf Stangl, a director at Reynolds Consumer Products (NASDAQ:REYN) , reported the purchase of 4,705 common shares in open-market transactions on March 18, 2026, valued at approximately $99,000, according to an SEC Form 4 filing . Transaction value based on SEC Form 4 weighted average purchase price ($21.06). Reynolds Consumer Products Inc. is a leading producer of consumer packaging and disposable goods, with a broad portfolio of established brands and private label offerings. Strategic focus on both branded and store brand products enhances resilience and positions Reynolds as a key supplier in the packaging and household products sector. Continue reading
Earnings Call Insights: Cytosorbents Corporation (CTSO) Q4 2025 Management View CEO Phillip Chan described 2025 as “a transitional year for the company, during which we made measurable progress across four key priorities,” including driving sales growth outside of Germany, advancing DrugSorb-ATR through the FDA process, and restructuring for long-term success in Germany. He highlighted that “full ...
Earnings Call Insights: Cytosorbents Corporation (CTSO) Q4 2025 Management View CEO Phillip Chan described 2025 as “a transitional year for the company, during which we made measurable progress across four key priorities,” including driving sales growth outside of Germany, advancing DrugSorb-ATR through the FDA process, and restructuring for long-term success in Germany. He highlighted that “full year 2025 sales revenues increased 4% to $37.1 million, representing record core product sales,” with direct sales outside Germany increasing 13% and distributor sales up 11.4%. CEO Chan reported a 10% decline in German sales to $11.8 million, attributed to restructuring, but noted “early signs of improvement in the first quarter of 2026” in Germany. He also detailed the launch of the PuriFi hemoperfusion pump and the HotSwap cartridge exchange system, with PuriFi aiming to “expand access in regions with limited dialysis infrastructure.” On DrugSorb-ATR, CEO Chan said, “we made important progress with the FDA. While our initial De Novo submission was denied, the appeal outcome provided two critical positives. One, there were no concerns regarding device safety; and two, there was alignment that a new submission can focus only on the remaining open items.” CFO Peter Mariani stated, “Full year 2025 revenue was $37.1 million, up 4% compared to a year ago and flat on a constant currency basis... Gross margin was 71% for the year compared to 70% for 2024.” He added, “operating loss for 2025 improved by 10% to $14.7 million compared to $16.5 million in 2024.” Outlook CEO Chan confirmed the company’s focus remains on “consistent revenue growth, executing the Germany turnaround, advancing DrugSorb-ATR towards FDA market authorization and achieving cash flow breakeven.” CFO Mariani indicated, “we expect operating cash burn to continue to decrease as these working capital dynamics normalize over the first half of the year and now expect to be operating cash flow breakeven in the seco...